Blauvelt, A., Strober, B., Langley, R., Burge, D., Pisenti, L., Yassine, M., Kavanagh, S., Arendt, C., Rolleri, R. and Reich, K. (2018) “Safety of Certolizumab Pegol in Chronic Plaque Psoriasis: Cumulative Data Over 48 Weeks’ Exposure from Phase 3, Multicenter, Randomized, Placebo-Controlled Studies”, SKIN The Journal of Cutaneous Medicine, 2(S1), p. S16. doi: 10.25251/skin.2.supp.16.